Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Cat . Non | Espèces | Description du produit | Structure | Pureté | Caractéristique |
---|---|---|---|---|---|
VED-H5228 | Human | Human VEGF-D Protein, His Tag |
|
Human VEGF R3, Fc Tag (Cat. No. FL4-H5251) captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Human VEGF-D, His Tag (Cat. No. VED-H5228) with an affinity constant of 19.7 nM as determined in a SPR assay (Biacore T200) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Sozinibercept | OPT-302; VGX-300 | Phase 3 Clinical | Orphan Europe Sarl | Neovascularization, Pathologic; Retinal Diseases; Diabetic macular oedema; Retinal Degeneration; Eye Diseases; Macular Degeneration | Details |
EG-016 | EG-016; Ad-VEGF-A | Phase 2 Clinical | Ark Therapeutics Ltd | Peripheral Vascular Diseases | Details |
EG-011 | EG-011; Ad-VEGF-D | Phase 2 Clinical | Ark Therapeutics Ltd | Angina Pectoris | Details |
Sozinibercept | OPT-302; VGX-300 | Phase 3 Clinical | Orphan Europe Sarl | Neovascularization, Pathologic; Retinal Diseases; Diabetic macular oedema; Retinal Degeneration; Eye Diseases; Macular Degeneration | Details |
EG-016 | EG-016; Ad-VEGF-A | Phase 2 Clinical | Ark Therapeutics Ltd | Peripheral Vascular Diseases | Details |
EG-011 | EG-011; Ad-VEGF-D | Phase 2 Clinical | Ark Therapeutics Ltd | Angina Pectoris | Details |
This web search service is supported by Google Inc.